Tuberculosis News and Research

Latest Tuberculosis News and Research

UEM, San Diego School of Medicine enter partnership to address medical human resource needs in Mozambique

Aimed at enhancing the capacity of Mozambique's flagship medical school, Universidade Eduardo Modlane (UEM), in pre- and postgraduate medical education, the University of California, San Diego School of Medicine and UEM entered into a partnership in 2007 to address both short and long-term medical human resource needs in Mozambique.

7 Oct 2010

Donors pledge nearly $12b for Global Fund, missing lowest funding target

Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, "higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world," the Financial Times reports.

7 Oct 2010

WHO Eastern Mediterranean meeting opens in Cairo

The 57th WHO Eastern Mediterranean regional meeting opened Sunday in Cairo, Egypt, the Emirates News Agency reports.

6 Oct 2010

Miller-Mccune examines impact of limited access to schistosomiasis drug in Africa

Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel the only commercially available treatment for the disease.

6 Oct 2010

Obama administration expected to announce $4B pledge to Global Fund

The Obama administration is expected on Tuesday to announce a large increase in its pledge to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and to call for reform of the organization," the Wall Street Journal reports.

6 Oct 2010

AHF applauds Obama administration for reasserting U.S. leadership in contributions to fight global AIDS

AIDS Healthcare Foundation (AHF) today lauded the Obama administration's announcement that it will seek $4 billion for the Global Fund to Fight HIV/AIDS, Malaria and Tuberculosis over the next three years—a 38% increase over what has been provided in the previous three-year period. The U.S. also urged better management of grants by participating countries, as well as increased accountability and efficiency by the Global Fund.

6 Oct 2010

Global health fund to get big boost from U.S.

The Wall Street Journal: "The Obama administration is expected on Tuesday to announce a large increase in its pledge to the Global Fund to Fight AIDS, Tuberculosis and Malaria, and to call for reform of the organization. The pledge of $4 billion over the next three fiscal years to the Geneva-based organization comes as governments and donors around the world have slowed increases in spending to combat HIV/AIDS, with weaker economies straining budgets."

6 Oct 2010

Chevron Corporation raises $25 million for Global Fund

Chevron Corporation today announced that it will commit an additional $25 million to The Global Fund to Fight AIDS, Tuberculosis and Malaria, raising its 6-year investment in the organization to $55 million.

6 Oct 2010

First Edition: October 5, 2010

Today's headlines include reports on the midterm elections and recent polls as well as the latest developments related to Medicaid expansion.

5 Oct 2010

NIH awards $4 million grant to develop novel genetic strategy for combating tuberculosis

William R. Jacobs, Jr., Ph.D., professor of microbiology & immunology and of genetics at Albert Einstein College of Medicine of Yeshiva University, who is also a Howard Hughes Medical Institute (HHMI) investigator, has been awarded a three-year, $4 million grant from the National Institutes of Health to develop a novel genetic strategy for combating tuberculosis (TB). TB causes almost two million deaths each year, making it the world's most deadly bacterial infection.

5 Oct 2010

Media examines PEPFAR hearing, calls for more HIV funding ahead of Global Fund replenishment meeting

Ahead of the replenishment meeting for the Global Fund to Fight AIDS, Tuberculosis and Malaria, which kicks off today in New York, Inter Press Service examines the Obama administration's HIV/AIDS funding commitments.

5 Oct 2010

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.

5 Oct 2010

FDA awards $2.9 million to support tuberculosis research projects

The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will help with the diagnosis, treatment, and prevention of tuberculosis (TB).

5 Oct 2010

Media outlets look ahead to next week's Global Fund replenishment meeting

Ahead of next week's replenishment meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria in New York, IRIN/PlusNews examines the challenges associated with trying to ramp up programs worldwide to meet global health targets.

4 Oct 2010

Scientist discovers novel pathogen from Mycobacterium tuberculosis complex

Kathleen Alexander, associate professor of wildlife in Virginia Tech's College of Natural Resources and Environment, has discovered a novel tuberculosis (TB) species in the Mycobacterium tuberculosis complex, a group of pathogens that have adapted by using mammals as hosts. It has been nearly two decades since a new organism was identified in this group; the majority were discovered in the early and mid 20th century.

3 Oct 2010

GSA urges treatment of sepsis as a medical emergency

The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. "Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care," said Konrad Reinhart, M.D., Chairman of the GSA and director of the Department of Anesthesiology and Intensive Care Medicine, University Hospital of the Friedrich Schiller, University of Jena, Germany.

1 Oct 2010

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

1 Oct 2010

U.N. agencies' report examines global progress in fight against HIV/AIDS

"A record 1.2 million people in low- and middle-income countries started antiretroviral therapy for HIV/AIDS in 2009" - a 30 percent increase from the previous year and a 13-fold increase in six years, according to a joint report released Tuesday by the WHO, UNICEF and UNAIDS, Reuters reports. In total, the report found that 5.25 million people received antiretroviral therapy (ART) in 2009, three-quarters of them living in Africa (Migiro, 9/28).

30 Sep 2010

Opinions: U.S. aid to Pakistan; MDGS; GHI and Global Fund

The U.S. military has been working hard to provide flood assistance, but most of that is invisible to Pakistanis, David Ignatius writes in a Washington Post opinion piece. The article examines the views of Pakistani flood victims, including criticism of their own government's response.

30 Sep 2010

Significant progress made universally in increasing access to HIV/AIDS services: Report

Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.

29 Sep 2010